Response rate and progression-free survival in locally advanced or metastatic primary lung adenocarcinoma treated with gefitinib /
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Book |
| Language: | English |
| Published: |
2009.
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 00937cam a2200241 a 4500 | ||
|---|---|---|---|
| 001 | u771811 | ||
| 003 | SIRSI | ||
| 005 | 200905281527 | ||
| 008 | 090528s2009 my a t 000 0 eng | ||
| 040 | |a UMP | ||
| 096 | |a WB115 |b UM 2009 Muv | ||
| 100 | 0 | |a Muventhiran Ruthranesan. | |
| 245 | 1 | 0 | |a Response rate and progression-free survival in locally advanced or metastatic primary lung adenocarcinoma treated with gefitinib / |c Muventhiran a/l Ruthranesan. |
| 260 | |c 2009. | ||
| 300 | |a ix, leaves 52 : |b col. ill. ; |c 30 cm. | ||
| 502 | |a Dissertation (M.Int.Med) -- Department of Medicine, Faculty of Medicine, University Malaya, 2009 | ||
| 504 | |a Bibliography: leaves 49-52. | ||
| 650 | 1 | 2 | |a Adenocarcinoma. |
| 650 | 2 | 2 | |a Epidermal Growth Factor. |
| 710 | 2 | 0 | |a Universiti Malaya. |b Jabatan Perubatan. |
| 900 | |a RAH | ||
| 596 | |a 2 | ||
| 999 | |a WB115 UM 2009 MUV |w NLM |c 1 |i A503124658 |d 10/7/2009 |f 10/7/2009 |g 1 |l TESIS |m P02MEDKL |r Y |s Y |t TESIS |u 10/7/2009 | ||